Magnetic pulses reduce movement stiffness
- Trial ID
- NCT07306104
- Official Title
- The Effect of Long-term Treatment of Parkinson's Disease With T-PEMF
- Goal
- Magnetic pulses reduce movement stiffness
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University of Southern Denmark
- Study Type
- INTERVENTIONAL
- Enrollment
- 90 participants
- Conditions
- PARKINSON DISEASE (Disorder)
- Interventions
- Transcranial pulsed electromagnetic fields (T-PEMF), Sham (No Treatment)
Plain-Language Summary
Testing whether long-term sessions of transcranial pulsed electromagnetic fields can ease motor symptoms and support brain function in people with mild Parkinson's. The treatment uses noninvasive electromagnetic pulses over the scalp to gently modulate brain activity and promote neuroplasticity, and it is compared with a sham procedure while participants stay on their usual, stable Parkinson medications rather than replacing levodopa. Adults 18 and up with idiopathic Parkinson's at Hoehn and Yahr stage 1 or 2 who can follow procedures and have an MMSE score over 22 may qualify; people with brain implants, epilepsy, recent medication changes, certain anticoagulant use, prior stroke, pregnancy, or other neurological disorders are excluded.
Locations
- Odense University Hospital, Odense, Denmark
- University of Southern Denmark, Odense, Denmark
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Transcranial pulsed electromagnetic fields (T-PEMF). Testing whether long-term sessions of transcranial pulsed electromagnetic fields can ease motor symptoms and support brain function in people with mild Parkinson's. The treatment uses noninvasive electromagnetic pulses over the scalp to gently modulate brain activity and promote neuroplasticity, and it is compared with a sham procedure while participants stay on their usual, stable Parkinson medications rather than replacing levodopa. Adults 18 and up with idiopathic Parkinson's at Hoehn and Yahr stage 1 or 2 who can follow procedures and have an MMSE score over 22 may qualify; people with brain implants, epilepsy, recent medication changes, certain anticoagulant use, prior stroke, pregnancy, or other neurological disorders are excluded.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 11 months.